{"SLR NAME":"Effective public health measures to mitigate the spread of COVID 19: a systematic review","References":[{"title1":"The Use of Digital Tools to Mitigate the COVID-19 Pandemic: Comparative Retrospective Study of Six Countries","References":[{"title2":"Outpacing the Virus: Digital Response to Containing the Spread of COVID-19 while Mitigating Privacy Risks","References":[]},{"title2":"Being Prepared for a Pandemic","References":[{"title3":"Estimates of HIV Incidence, Prevalence and Canada's Progress on Meeting the 90-90-90 HIV Targets"},{"title3":"Summary: Estimates of HIV Incidence, Prevalence and Canada's Progress on Meeting the 90-90-90 HIV Targets"},{"title3":"A cross-sectional investigation of HIV prevalence and risk factors among African, Caribbean and Black people in Ontario: The A/C study"},{"title3":"Experiences with Telemedicine for HIV Care during the COVID-19 Pandemic: A Mixed-Methods Study"},{"title3":"Understanding COVID-19 risks and vulnerabilities among black communities in America: The lethal force of syndemics"},{"title3":"HIV infection and COVID-19: Risk factors for severe disease"},{"title3":"The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective"},{"title3":"Black and latino persons living with HIV evidence risk and resilience in the context of COVID-19: A mixed-methods study of the early phase of the pandemic"},{"title3":"Racial Disparity of Coronavirus Disease 2019 in African American Communities"},{"title3":"Impact of COVID-19 on the Delivery of STBBI-Related Services in Canada, including Harm Reduction Services, for African, Caribbean and Black People"},{"title3":"Associations between HIV-related stigma, racial discrimination, gender discrimination, and depression among HIV-positive African, Caribbean, and Black women in Ontario, Canada"},{"title3":"Mental health among transgender women living with HIV in Canada: Findings from a national community based research study"},{"title3":"A structural equation model of factors contributing to quality of life among African and Caribbean women living with HIV in Ontario, Canada"},{"title3":"What does 'access to health care' mean?"},{"title3":"COVID-19 pandemic disrupts HIV continuum of care and prevention: Implications for research and practice concerning Community-Based organizations and frontline providers"},{"title3":"Cost of Living in BC"},{"title3":"It's Now $2471 a Month on Average to Rent an Apartment in B.C.: Report"},{"title3":"Whatever happened to qualitative description?"},{"title3":"The worldwide impact of telemedicine during COVID-19: Current evidence and recommendations for the future"},{"title3":"A scoping review of virtual care in the health system: Infrastructures, barriers, and facilitators"},{"title3":"&quot;It is like that, we didn't understand each other&quot;: Exploring the influence of patient-provider interactions on prevention of mother-to-child transmission of HIV service use in rural Tanzania"},{"title3":"Barriers in accessing HIV care for francophone African, Caribbean and Black people living with HIV in Canada: A scoping review"},{"title3":"Impact of the COVID-19 pandemic on HIV healthcare service engagement, treatment adherence, and viral suppression in the united states: A systematic literature review"},{"title3":"COVID-19, telemedicine, and patient empowerment in HIV care and research"},{"title3":"The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: A systematic review"},{"title3":"HIV care meets telehealth: A review of successes, disparities, and unresolved challenges"},{"title3":"The benefits of psychosocial interventions for mental health in people living with HIV: A systematic review and meta-analysis"},{"title3":"Mental health and HIV/AIDS: The need for an integrated response"},{"title3":"Social and behavioral impacts of COVID-19 on people living with HIV: Review of the first year of research"},{"title3":"Experiences with telemedicine for HIV care in two federally qualified health centers in Los Angeles: A qualitative study"},{"title3":"Changes in the Socioeconomic Situation of Canada's Black Population, 2001 to 2016"},{"title3":"Impact of the COVID-19 pandemic on provision of HIV/AIDS services for key populations"},{"title3":"The Contribution of Pandemic Relief Benefits to the Incomes of Canadians in 2020"},{"title3":"Study: A Labour Market Snapshot of Black Canadians during the Pandemic"},{"title3":"Socio-structural factors and HIV care engagement among people living with HIV during the COVID-19 pandemic: A qualitative study in the united states"},{"title3":"Barriers to and facilitators of accessing HIV services for street-involved youth in Canada and Kenya"}]},{"title2":"Flattening the curve on COVID-19 - How Korea responded to a pandemic using ICT","References":[]},{"title2":"Coronavirus (COVID-19) Cases - Statistics and Research","References":[]},{"title2":"News Highlights","References":[]},{"title2":"From SARS to COVID-19: the Singapore journey","References":[{"title3":"Coronavirus disease 2019 (COVID-2019): situation report - 99 (28 April 2020)"},{"title3":"Epidemiology and control of SARS in Singapore"},{"title3":"Interrupting transmission of COVID-19: lessons from containment efforts in Singapore"},{"title3":"Pandemic preparedness: Nationally-led simulation to test hospital systems"},{"title3":"The Singaporean response to the SARS outbreak: knowledge sufficiency versus public trust"},{"title3":"Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore - January 2-February 29, 2020"},{"title3":"How does TraceTogether work?"},{"title3":"20 April 2020 - one month on"},{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures"},{"title3":"Infectious Diseases Act (Chapter 137)"},{"title3":"Scaling up of COVID-19 testing"},{"title3":"Situation report - 27 April 2020: coronavirus disease (COVID-19)"},{"title3":"Circuit breaker to minimise further spread of COVID-19"},{"title3":"Containing COVID-19 spread at foreign worker dormitories"},{"title3":"Tackling transmissions in migrant worker clusters 22 Apr 2020"},{"title3":"Testing for SARS-CoV-2: can we stop at two?"},{"title3":"De-isolating COVID-19 suspect cases: a continuing challenge"},{"title3":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Facing Covid-19 in Italy - ethics, logistics, and therapeutics on the epidemic's front line"},{"title3":"COVID-19 and its impact on neurosurgery: our early experience in Singapore"},{"title3":"Love in the time of coronavirus: training and service during COVID-19"},{"title3":"Going virtual to support anatomy education: a STOP GAP in the midst of the Covid-19 pandemic"},{"title3":"Pandemics and their impact on medical training: lessons from Singapore"}]},{"title2":"Mandatory Stay-Home Notice for Work Pass Holders with Travel History to Mainland China","References":[]},{"title2":"ICA: All Travelers Arriving In Singapore From 27 March 2020, 0900 Hours, Must Submit Health Declaration Via The SG Arrival Card E-Service","References":[]},{"title2":"News Highlights","References":[]},{"title2":"Transforming Singapore Through Technology","References":[]},{"title2":"What is SafeEntry?","References":[]},{"title2":"Guidance For The Use Of Masks And Face Shields","References":[]},{"title2":"Coronavirus: DOD Response Timeline","References":[]},{"title2":"Thinking Globally, Acting Locally : The U.S. Response to Covid-19","References":[]},{"title2":"Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US","References":[]},{"title2":"Fact Sheet: DHS Notice of Arrival Restrictions on China, Iran and Certain Countries of Europe","References":[]},{"title2":"Legal Emergency Coronavirus Measures","References":[]},{"title2":"Domande Frequenti","References":[]},{"title2":"Coronavirus: sospesi tutti i collegamenti aerei tra Italia e Cina","References":[]},{"title2":"The Ministry of Health and the CCAA agree to increase the sensitivity of the system for the early detection of the coronavirus","References":[]},{"title2":"Royal Decree 463/2020, of March 14, declaring the state of alarm for the management of the health crisis situation caused by COVID-19","References":[]},{"title2":"STOP COVID19 CAT","References":[]},{"title2":"Asistencia COVID-19","References":[]},{"title2":"CoronaMadrid","References":[]},{"title2":"Salut","References":[{"title3":"Early-life origins of life-cycle well-being: research and policy implications"},{"title3":"Living with the past: evolution, development, and patterns of disease"},{"title3":"Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int. J. Epidemiol. England; 2002. p. 285-93."},{"title3":"Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention"},{"title3":"Early childhood interventions: &quot;Proven results, future promise"},{"title3":"Aos S, Lieb R, Mayfield J, Miller M, Pennucci A. Benefits and Costs of Prevention and Early Intervention Programs for Youth | Office of Justice Programs [Internet]. Available from: https://www.ojp.gov/ncjrs/virtual-library/abstracts/benefits-and-costs-prevention-and-early-intervention-programs-youth."},{"title3":"Cannon JS, Kilburn MR, Karoly LA, Mattox T, Muchow AN, Buenaventura M. Investing Early: Taking Stock of Outcomes and Economic Returns from Early Childhood Programs. Rand Heal Q [Internet]. 2018;7:6. Available from: https://europepmc.org/articles/PMC6075808."},{"title3":"Karoly LA, Bigelow JH. The Economics of Investing in Universal Preschool Education in California. Econ Invest Univers Presch Educ Calif [Internet]. RAND Corporation; 2005 [cited 2021 Dec 9]; Available from: https://www.rand.org/pubs/monographs/MG349.html."},{"title3":"Cost-effective early childhood development programs from preschool to third grade"},{"title3":"The economic returns to early Childhood Education"},{"title3":"Nores M, Barnett WS. Benefits of early childhood interventions across the world: (Under) Investing in the very young. Econ Educ Rev [Internet]. 2010;29:271-82. Available from: https://www.sciencedirect.com/science/article/pii/S027277570900106X."},{"title3":"Cost-effectiveness of the Family Nurse Partnership (FNP) programme in England: evidence from the building blocks trial"},{"title3":"Bell K, Corbacho B, Ronaldson S, Richardson G, Torgerson D, Robling M et al. The impact of pre and perinatal lifestyle factors on child long term health and social outcomes: a systematic review. Health Econ Rev [Internet]. 2018;8:2. Available from: 10.1186/s13561-018-0186-6."},{"title3":"Preterm birth lifetime costs in the United States in 2016: an update"},{"title3":"Edvardsson K, Garvare R, Ivarsson A, Eurenius E, Mogren I, Nystrom ME. Sustainable practice change: Professionals' experiences with a multisectoral child health promotion programme in Sweden. BMC Health Serv Res [Internet]. 2011;11:61. Available from: 10.1186/1472-6963-11-61."},{"title3":"Elisabeth Nystrom M, Hoog E, Garvare R, Weinehall L, Ivarsson A. Change and learning strategies in large scale change programs. J Organ Chang Manag [Internet]. Emerald Group Publishing Limited; 2013;26:1020-44. Available from: 10.1108/JOCM-08-2012-0132."},{"title3":"Haggstrom J, Sampaio F, Eurenius E, Pulkki-Brannstrom AM, Ivarsson A, Lindkvist M et al. Is the Salut Programme an effective and cost-effective universal health promotion intervention for parents and their children? A register-based retrospective observational study. BMJ Open [Internet]. 2017/09/25. 2017;7:e016732. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28939578."},{"title3":"Feldman I, Eurenius E, Haggstrom J, Sampaio F, Lindkvist M, Pulkki-Brannstrom A-M et al. Effectiveness and cost-effectiveness of the Salut Programme: A universal health promotion intervention for parents and children - Protocol of a register-based retrospective observational study. BMJ Open. 2016;6."},{"title3":"Swedish Association of Local Authorities and Regions (SALAR). [Sveriges kommuner och Regioner (SKR)]. Cost per patient database [Kostnad per patient, KPP] [Internet]. [cited 2021 Oct 11]. Available from: https://skr.se/ekonomijuridikstatistik/statistik/kostnadperpatientkpp.1076.html."},{"title3":"Statistics Sweden [Statistiska centralbyran]. Consumer Price Index (CPI) [Konsumentprisindex (KPI)] [Internet]. Available from: https://www.scb.se/hitta-statistik/statistik-efter-amne/priser-och-konsumtion/konsumentprisindex/konsumentprisindex-kpi/pong/tabell-och-diagram/konsumentprisindex-kpi/kpi-faststallda-tal-1980100/."},{"title3":"CCEMG - EPPI-Centre. Cost Converter v.1.4: web-based tool for adjusting estimates of cost using IMF source dataset for PPP [Internet]. [cited 2021 Jun 3]. Available from: https://eppi.ioe.ac.uk/costconversion/default.aspx."},{"title3":"Abadie A, Imbens GW. Large Sample Properties of Matching Estimators for Average Treatment Effects. Econometrica [Internet]. 2006;74:235-67. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1468-0262.2006.00655.x."},{"title3":"Abadie A, Imbens GW. On the Failure of the Bootstrap for Matching Estimators. Econometrica [Internet]. 2008;76:1537-57. Available from: https://onlinelibrary.wiley.com/doi/abs/10.3982/ECTA6474."},{"title3":"Hartfiel N, Edwards R. Cost-consequence analysis of public health interventions. 2019. p. 233-47."},{"title3":"Henderson J, Carson C, Redshaw M. Impact of preterm birth on maternal well-being and women's perceptions of their baby: a population-based survey. BMJ Open [Internet]. 2016;6:e012676. Available from: https://bmjopen.bmj.com/content/6/10/e012676.abstract"},{"title3":"Gutbrod T, Wolke D, Soehne B, Ohrt B, Riegel K. Effects of gestation and birth weight on the growth and development of very low birthweight small for gestational age infants: a matched group comparison. Arch Dis Child - Fetal Neonatal Ed [Internet]. 2000;82:F208 LP-F214. Available from: http://fn.bmj.com/content/82/3/F208.abstract."},{"title3":"Rosholm M, Paul A, Bleses D, Hojen A, Dale S, Jensen P, ARE IMPACTS OF EARLY INTERVENTIONS IN THE SCANDINAVIAN WELFARE STATE CONSISTENT WITH A HECKMAN CURVE? A META-ANALYSIS. P,. J Econ Surv [Internet]. 2021;35:106-40. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/joes.12400."},{"title3":"Beckmann K, Garmo H, Franck Lissbrant I, Stattin P. The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries. Cancers (Basel). 2021;13."},{"title3":"Baba S, Wikstrom A-K, Stephansson O, Cnattingius S. Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG An Int J Obstet Gynaecol [Internet]. 2013;120:456-62. Available from: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.12067."},{"title3":"Wikstrom A-K, Cnattingius S, Galanti MR, Kieler H, Stephansson O. Effect of Swedish snuff (snus) on preterm birth. BJOG An Int J Obstet Gynaecol [Internet]. 2010;117:1005-10. Available from: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/j.1471-0528.2010.02575.x."},{"title3":"Nutbeam D. Evaluating Health Promotion:Progress, Problems and solutions. Health Promot Int [Internet]. 1998;13:27-44. Available from: 10.1093/heapro/13.1.27."}]},{"title2":"Politica de privacidad","References":[{"title3":"A contribuicao da atencao primaria a saude na rede SUS de enfrentamento a Covid-19"},{"title3":"?Es la atencion primaria de salud integral parte de la respuesta a la pandemia de Covid-19 en Latinoamerica?"},{"title3":"Secretaria de Saude define planejamento com agentes comunitarios de saude"},{"title3":"Complexidade e potencialidade do trabalho dos Agentes Comunitarios de Saude no Brasil contemporaneo"},{"title3":"The Family Health Strategy coverage in Brazil: what reveal the 2013 and 2019 National Health Surveys"},{"title3":"Estimativas e projecoes populacionais para pequenos dominios: uma avaliacao da precisao para municipios do Rio de Janeiro em 2000 e 2007"},{"title3":"Cobertura de planos de saude na populacao brasileira, segundo a Pesquisa Nacional de Saude, 2013"},{"title3":"As multiplas fronteiras presentes no atendimento a saude do estrangeiro em Corumba, Brasil"},{"title3":"Saude na fronteira brasileira: politicas publicas e acesso a servicos"}]},{"title2":"Take your self-assessment of COVID-19","References":[]},{"title2":"About the Spain Travel Health program","References":[]},{"title2":"The Government announces new measures to prevent the spread of the new coronavirus COVID-19","References":[]},{"title2":"Notas De Prensa","References":[]},{"title2":"Behind the mask. Journey through an epidemic: some observations of contrasting public health responses to SARS","References":[]},{"title2":"FAQs from Foreign Media","References":[]},{"title2":"Coronavirus disease-19 FAQs","References":[]},{"title2":"Entry Restrictions","References":[{"title3":"Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review"},{"title3":"An integrative review of the limited evidence on international travel bans as an emerging infectious disease disaster control measure"},{"title3":"Japanese tourism and the SARS epidemic of 2003"},{"title3":"Economic impact of the 2015 MERS outbreak on the Republic of Korea's tourism-related industries"},{"title3":"Epidemiology and quarantine measures during COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan in 2020: a descriptive analysis"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2"},{"title3":"Can we contain the COVID-19 outbreak with the same measures as for SARS?"},{"title3":"Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study"}]},{"title2":"News Highlights","References":[]},{"title2":"20 April 2020 - One Month On","References":[]},{"title2":"News Highlights","References":[]},{"title2":"Seniors To Receive First Batch Of TraceTogether Tokens","References":[]},{"title2":"CDC releases resources to assist states to open","References":[]},{"title2":"Case Investigation and Contact Tracing: Part of a Multipronged Approach to Fight the COVID-19 Pandemic","References":[]},{"title2":"Considerations for Travelers-Coronavirus in the US","References":[]},{"title2":"Which US states require masks and which 2 don't at all?","References":[]},{"title2":"Researchers Continue Quest to Contain Spread of COVID-19: Digital technologies aim to accelerate contact tracing","References":[]},{"title2":"Most states won't use Apple and Google's COVID-19 contact-tracing","References":[]},{"title2":"Measures for the Containment and Management of the Epidemiological Emergency","References":[]},{"title2":"FAQs on the Italian Government's #ImStayingHome Decree","References":[]},{"title2":"Coronavirus: De Micheli signs Decree on self-isolation for those returning to Italy","References":[]},{"title2":"Italian nationals returning to Italy and foreigners in Italy","References":[]},{"title2":"DECREE-LAW April 30, 2020, n. 28 Article 6","References":[]},{"title2":"Spain revises coronavirus death toll down by nearly 2,000","References":[]},{"title2":"The real Covid-19 death toll in Spain: at least 44,868 victims","References":[]},{"title2":"Citizens from Wuhan initiate quarantine at the Gomez Ulla Hospital","References":[]},{"title2":"Spanish town faces police lockdown to contain coronavirus","References":[]},{"title2":"Cataluna confina a 70.000 personas en cuatro municipios por el coronavirus","References":[]},{"title2":"A Comprehensive Review of the COVID-19 Pandemic and the Role of IoT, Drones, AI, Blockchain, and 5G in Managing its Impact","References":[]},{"title2":"Diagnostic Strategy, Surveillance and Control In The Phase of Transition of the Pandemic of COVID-19 Monitoring Indicators","References":[]},{"title2":"The Council of Ministers approves the Transition Plan towards a New Normality","References":[]},{"title2":"Today the order that establishes a 14-day quarantine for all people from abroad comes into force","References":[]},{"title2":"Order SND/422/2020, of May 19, regulating the conditions for the mandatory use of a mask during the health crisis situation caused by COVID-19","References":[]},{"title2":"Successful Elimination of Covid-19 Transmission in New Zealand","References":[]},{"title2":"Ensuring the Safety of COVID-19 Vaccines in the United States","References":[]}]},{"title1":"Impact of National Containment Measures on Decelerating the Increase in Daily New Cases of COVID-19 in 54 Countries and 4 Epicenters of the Pandemic: Comparative Observational Study","References":[{"title2":"The Middle East Respiratory Syndrome (MERS)","References":[]},{"title2":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features","References":[{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"List of blue print priority diseases"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November to 31 July 2003"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Analysis on the characteristics of blood serum Ab-IgG detective result of severe acute respiratory syndrome patients in Guangzhou, China"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong province, China, 2003"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Pegulated interferon-a protects type I pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a Toll-like-receptor-related TRAF3-independent mechanism"},{"title3":"IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome in Guangdong, People's Republic of China, in February 2003"},{"title3":"Severe acute respiratory syndrome"},{"title3":"The severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Index patient and SARS outbreak in Hong Kong"},{"title3":"The severe acute respiratory syndrome coronavirus in tears"},{"title3":"Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients"},{"title3":"Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong"},{"title3":"Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units"},{"title3":"Update 95-SARS: chronology of a serial killer"},{"title3":"Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"Viral load distribution in SARS outbreak"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome"},{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"SARS: clinical features and diagnosis"},{"title3":"Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features"},{"title3":"Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome"},{"title3":"Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Temporal patterns of hepatic dysfunction and disease severity in patients with SARS"},{"title3":"Thin section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study"},{"title3":"Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome. A preliminary study"},{"title3":"Hemophagocytic syndrome and infection"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys"},{"title3":"DNA vaccine of SARS-CoV S gene induces antibody response in mice"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Pandemic planning in China: applying lessons from severe acute respiratory syndrome"},{"title3":"Infection prevention and control measures for acute respiratory infections in healthcare settings: an update"}]},{"title2":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC)"},{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS coronavirus outbreak: implications for emerging viral infections"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Helicobacter pylori multiplex serology"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"SARS: epidemiology"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012-2015"},{"title3":"Estimating the risk of Middle East Respiratory Syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Severe Acute Respiratory Syndrome (SARS)-lessons for future pandemics"},{"title3":"Public Health Network Structure and Collaboration Effectiveness during the 2015 MERS outbreak in South Korea: an institutional collective action framework"},{"title3":"Leung Gm Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"CDC. CDC Advises Travelers to Avoid All Nonessential Travel to China. https://www.cdc.gov/media/releases/2020/s0128-travelers-avoid-china.html (2 April 2020, date last accessed)."}]},{"title2":"Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV","References":[{"title3":"Review of bats and SARS"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular mechanisms of coronavirus RNA capping and methylation"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses:A statement of the Coronavirus Study Group"},{"title3":"WHO Named the New Pneumonia &quot;COVID-19&quot;"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"2015 MERS outbreak in Korea: Hospital-to-hospital transmission"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The 2019 Novel Coronavirus Resource"},{"title3":"NCBI Database. 2019-nCoV"},{"title3":"GSAID Database. 2020 Coronavirus"},{"title3":"NCBI Blast"},{"title3":"Zpicture"},{"title3":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets"},{"title3":"Prospects for inferring very large phylogenies by using the neighbor-joining method"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Weekly Epidemiological Record, 2013, vol. 88, 35 [full issue]"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Severe acute respiratory syndrome-Singapore, 2003"},{"title3":"Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003"},{"title3":"The SARS wake-up call"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"Epidemic Update and Risk Assessment of 2019 Novel Coronavirus"},{"title3":"Return of the Coronavirus: 2019-nCoV"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus"},{"title3":"Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4)"},{"title3":"Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)"},{"title3":"Incubation periods of acute respiratory viral infections: A systematic review"},{"title3":"Multiple contact dates and SARS incubation periods"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"SARS: Epidemiology"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The severe acute respiratory syndrome"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients"},{"title3":"Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Press Conference of the National Health Commission of the People's Republic of China on 3 February 2020"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Novel coronavirus: From discovery to clinical diagnostics"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Distribution of Pneumonia Infected by 2019-nCoV"},{"title3":"Real-time Updates of COVID-19 Epidemic in China"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Potential of large 'first generation' human-to-human transmission of 2019-nCoV"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research"},{"title3":"There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol"},{"title3":"SARS transmission, risk factors, and prevention in Hong Kong"},{"title3":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle"},{"title3":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003"},{"title3":"The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank"},{"title3":"The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season"},{"title3":"Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats"},{"title3":"Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again"},{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":"Treatment of SARS with human interferons"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection"},{"title3":"The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19"},{"title3":"High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo"},{"title3":"China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"Jumping species:A mechanism for coronavirus persistence and survival"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"SARS: Clinical virology and pathogenesis"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Coronaviruses post-SARS: Update on replication and pathogenesis"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"SARS: Clinical features and diagnosis"},{"title3":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"}]},{"title2":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","References":[{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations"},{"title3":"Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high-and low-risk groups in Qatar"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018"},{"title3":"Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness"},{"title3":"Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus"},{"title3":"Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus"},{"title3":"Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: a one-year study in Southeast Brazil"},{"title3":"Case fatality of SARS in mainland China and associated risk factors"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"The SARS epidemic in Hong Kong: what lessons have we learned?"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"Wuhan is expected to send 15 million passengers during Spring Festival in 2020 (in Chinese)"},{"title3":"An outbreak of NCIP (2019-nCoV) infection in China:Wuhan, Hubei Province, 2019-2020"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Characterizing the dynamics underlying global spread of epidemics"},{"title3":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities"},{"title3":"Frequently asked questions about SARS"},{"title3":"Real-time epidemic forecasting: challenges and opportunities"},{"title3":"Outbreak analytics: a developing data science for informing the response to emerging pathogens"},{"title3":"Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1"},{"title3":"MRC Centre for Global Infectious Disease Analysis: Wuhan coronavirus reports 1-3"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Announcement of the State Administration of Market Supervision, Ministry of Agriculture and Rural Affairs, and the National Forestry and Grass Bureau on banning wildlife trading (in Chinese)"}]},{"title2":"Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study","References":[{"title3":"Epidemic update and risk assessment of 2019 novel coronavirus 2020"},{"title3":"Update on COVID-19 as of 24:00 on March 10, 2020"},{"title3":"Coronavirus disease 2019 (COVID-19) situation report-47"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"Diagnosis and treatment guideline on pneumonia infection with 2019 novel coronavirus (5th trial edn)"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Ebola virus disease in West Africa:the first 9 months of the epidemic and forward projections"},{"title3":"Measurability of the epidemic reproduction number in data-driven contact networks"},{"title3":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"China census in 2018"},{"title3":"Notice on the postponement of the spring semester of 2020"},{"title3":"Reactive school closure weakens the network of social interactions and reduces the spread of influenza"},{"title3":"Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data"},{"title3":"The Incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Characteristics of COVID-19 infection in Beijing"},{"title3":"Effects of school closures, 2008 winter influenza season, Hong Kong"},{"title3":"Notice on extending the spring festival holiday of 2020"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Estimating the serial interval of the novel coronavirus disease (COVID-19): a statistical analysis using the public data in Hong Kong from January 16 to February 15, 2020"},{"title3":"Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020"},{"title3":"The serial interval of COVID-19 from publicly reported confirmed cases"},{"title3":"Transmission interval estimates suggest pre-symptomatic spread of COVID-19"},{"title3":"Early dynamics of transmission and control of COVID-19: a mathematical modelling study"},{"title3":"Estimating the asymptomatic proportion of 2019 novel coronavirus onboard the Princess Cruises ship, 2020"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Inclusion of 2019 novel coronavirus diseases (COVID-19) into statutory infectious disease management"},{"title3":"WHO chief praises containment efforts"}]},{"title2":"COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University &amp; Medicine","References":[]},{"title2":"Country &amp; Technical Guidance - Coronavirus disease (COVID-19)","References":[]},{"title2":"Updated WHO recommendations for international traffic in relation to COVID-19 outbreak","References":[]},{"title2":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report:44"},{"title3":"News / COVID-19:report 3: transmissibility of 2019-nCoV. 2020"},{"title3":"Factors that make an infectious disease outbreak controllable"},{"title3":"Coronavirus disease (COVID-2019) situation report:30"},{"title3":"Heterogeneity in estimates of the impact of influenza on population mortality: a systematic review"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Daily risk assessment on COVID-19"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Will COVID-19 go away on its own in warmer weather? Center for Communicable Disease Dynamics (CCDD) at the Harvard T.H. Chan School of Public Health"},{"title3":"Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review"},{"title3":"Mitigation strategies for pandemic influenza A: balancing conflicting policy objectives"},{"title3":"Closure of schools during an influenza pandemic"},{"title3":"Coronavirus action plan"},{"title3":"Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts"},{"title3":"The efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19)"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVD-19)"},{"title3":"The health impact of the 2014-15 Ebola outbreak"}]},{"title2":"Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak","References":[]},{"title2":"Quarantine alone or in combination with other public health measures to control COVID-19: A rapid Cochrane review","References":[{"title3":"Covid-19: risk factors for severe disease and death"},{"title3":"&quot;Evidence used to update the list of underlying medical conditions that increase a person's risk of severe illness from COVID-19&quot;, Centers for Disease Control and Prevention"},{"title3":"Coronaviruses pathogenesis, comorbidities and multi-organ damage - a review"},{"title3":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review"},{"title3":"Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis"},{"title3":"Chest CT findings related to mortality of patients with COVID-19: a retrospective case-series study"},{"title3":"Association between hypoxemia and mortality in patients with COVID-19"},{"title3":"Dexamethasone for the treatment of coronavirus disease (COVID-19): a review"}]},{"title2":"Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China","References":[{"title3":"Scientists are racing to model the next moves of a coronavirus that's still hard to predict"},{"title3":"WHO, Novel coronavirus (2019-nCoV) situation report - 11 (2020)."},{"title3":"WHO, Coronavirus disease 2019 (COVID-19) situation report - 51 (2020)."},{"title3":"CDC, 2019 Novel coronavirus (2019-nCoV); https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html (accessed 13 February 2020)."},{"title3":"Here's how computer models simulate the future spread of new coronavirus"},{"title3":"China's citywide quarantines: Are they ethical and effective?"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Spreading patterns of the influenza A (H1N1) pandemic"},{"title3":"Exponential growth in Ebola outbreak since May 14, 2014"},{"title3":"R. M. Anderson, R. M. May, Infectious Diseases of Humans: Dynamics and Control, Oxford Science Publications (Oxford Univ. Press, 1991)."},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"B. Prasse, M. A. Achterberg, L. Ma, P. Van Mieghem, Network-Based Prediction of the 2019-nCoV Epidemic Outbreak in the Chinese Province Hubei; arXiv:2002.04482 [physics, q-bio] (2020)."},{"title3":"S. Sanche et al, The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated; arXiv:2002.03268 [q-bio] (2020)."},{"title3":"A time delay dynamic system with external source for the local outbreak of 2019-nCoV"},{"title3":"WHO, Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) (2020)."},{"title3":"M. J. Keeling, P. Rohani, Modeling Infectious Diseases in Humans and Animals (Princeton Univ. Press, 2008)."},{"title3":"Contributions to the mathematical theory of epidemics:I. 1927"},{"title3":"WHO, Novel Coronavirus (2019-nCoV) Situation Report - 7 (2020)."},{"title3":"GeoNames Project, GeoNames. https://geonames.org (accessed 1 November 2019)."}]},{"title2":"Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK","References":[{"title3":"ECDC. Situation update worldwide, as of 13 April 2020: ECDC; 2020. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed 13 Apr 2020."},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Fancourt D. New study into psychological and social effects of Covid-19: UCL; 2020. https://www.ucl.ac.uk/news/2020/mar/new-study-psychological-and-social-effects-covid-19. Accessed 25 Mar 2020."},{"title3":"YouGov. COVID-19 Public Monitor. YouGov. https://yougov.co.uk/topics/health/explore/issue/Coronavirus. Accessed 31 Mar 2020."},{"title3":"Measured dynamic social contact patterns explain the spread of H1N1v influenza"},{"title3":"Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries"},{"title3":"Projecting social contact matrices in 152 countries using contact surveys and demographic data"},{"title3":"Reactive school closure weakens the network of social interactions and reduces the spread of influenza"},{"title3":"Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, et al. Age profile of susceptibility, mixing, and social distancing shape the dynamics of the novel coronavirus disease 2019 outbreak in China. Epidemiology. 2020. 10.1101/2020.03.19.20039107."},{"title3":"Social contacts and mixing patterns relevant to the spread of infectious diseases"},{"title3":"Office of National Statistics. Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland mid-2018. 2019. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland. Accessed 25 Mar 2020."},{"title3":"Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents"},{"title3":"Klepac P, Kucharski AJ, Conlan AJK, Kissler S, Tang M, Fry H, et al. Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project. Epidemiology. 2020. 10.1101/2020.02.16.20023754."},{"title3":"The construction of next-generation matrices for compartmental epidemic models"},{"title3":"Evaluating variability and uncertainty separately in microbial quantitative risk assessment using two R packages"},{"title3":"Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25. 10.2807/1560-7917.ES.2020.25.4.2000058."},{"title3":"Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. MedRxiv. 2020; https://www.medrxiv.org/CONTENT/10.1101/2020.01.23.20018549V2.abstract. Accessed 15 Apr 2020."},{"title3":"Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. bioRxiv. 2020. 10.1101/2020.01.23.916395."},{"title3":"Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). bioRxiv. 2020. 10.2139/ssrn.3526307."},{"title3":"Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak. MedRxiv. 2020. 10.1101/2020.02.09.20021261."},{"title3":"Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25. 10.2807/1560-7917.ES.2020.25.3.2000044."},{"title3":"Jung S-M, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases. J Clin Med Res. 2020;9. 10.3390/jcm9020523."},{"title3":"Zhuang Z, Zhao S, Lin Q, Cao P, Lou Y, Yang L, et al. Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea from 31 January to 1 March 2020. medRxiv. 2020; https://www.medrxiv.org/content/medrxiv/early/2020/03/10/2020.03.02.20030312.full.pdf. Accessed 15 Apr 2020."},{"title3":"Chong KC, Cheng W, Zhao S, Ling F, Mohammad KN. Monitoring disease transmissibility of 2019 novel coronavirus disease in Zhejiang, China. medRxiv. 2020; https://www.medrxiv.org/content/10.1101/2020.03.02.20028704v1.abstract."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The transmissibility of novel coronavirus in the early stages of the 2019-20 outbreak in Wuhan: exploring initial point-source exposure sizes and durations using scenario analysis"}]},{"title2":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe","References":[{"title3":"Complexity of the basic reproduction number (R0)"},{"title3":"Important concepts in mathematical modeling of infectious diseases"},{"title3":"Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe"},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"Estimates of the severity of COVID-19 disease"},{"title3":"Comment on Flaxman (2020): the illusory effects of non-pharmaceutical interventions on COVID-19 in Europe"}]},{"title2":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis","References":[{"title3":"COVID-19 coronavirus pandemic"},{"title3":"Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020"},{"title3":"Detection of air and surface contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in hospital rooms of infected patients"},{"title3":"Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center"},{"title3":"Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong"},{"title3":"Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong"},{"title3":"A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Community mitigation guidelines to prevent pandemic influenza: United States, 2017"},{"title3":"Rational use of face masks in the COVID-19 pandemic"},{"title3":"COVID-19: should cloth masks be used by healthcare workers as a last resort?"},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial"},{"title3":"Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: a systematic review and meta-analysis of randomized trials"},{"title3":"Reviews: rapid! Rapid! Rapid! . . . and systematic"},{"title3":"Cochrane handbook for systematic reviews of interventions, version 6"},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting"},{"title3":"Physical interventions to interrupt or reduce the spread of respiratory viruses"},{"title3":"Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis"},{"title3":"GRADE guidelines, 7: rating the quality of evidence:inconsistency"},{"title3":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients"},{"title3":"No clear choice between Newcastle-Ottawa Scale and Appraisal Tool for Cross-Sectional Studies to assess methodological quality in cross-sectional studies of health-related quality of life and breast cancer"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"},{"title3":"RoB 2: a revised tool for assessing risk of bias in randomised trials"},{"title3":"GRADE guidelines, 1: introduction:GRADE evidence profiles and summary of findings tables"},{"title3":"GRADE guidelines, 13: preparing summary of findings tables and evidence profiles:continuous outcomes"},{"title3":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments"},{"title3":"GRADE guidelines, 26: informative statements to communicate the findings of systematic reviews of interventions"},{"title3":"Controlling the risk of spurious findings from meta-regression"},{"title3":"Physical interventions to interrupt or reduce the spread of respiratory viruses, part 1: face masks, eye protection and person distancing:systematic review and meta-analysis"},{"title3":"Bayesian methods in meta-analysis and evidence synthesis"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial"},{"title3":"Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel"},{"title3":"Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014"},{"title3":"SARS-CoV-2 infection in health care workers: a retrospective analysis and a model study"},{"title3":"Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States"},{"title3":"Intubation of SARS patients: infection and perspectives of healthcare workers"},{"title3":"Which preventive measures might protect health care workers from SARS?"},{"title3":"High transmissibility of COVID-19 near symptom onset"},{"title3":"Association between 2019-nCoV transmission and N95 respirator use"},{"title3":"Lack of SARS transmission among public hospital workers, Vietnam"},{"title3":"Health care worker contact with MERS patient, Saudi Arabia"},{"title3":"Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient: Solano County, California, February 2020"},{"title3":"Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore"},{"title3":"Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015"},{"title3":"Risk of transmission via medical employees and importance of routine infection-prevention policy in a nosocomial outbreak of Middle East respiratory syndrome (MERS): a descriptive analysis from a tertiary care hospital in South Korea"},{"title3":"Transmission among healthcare worker contacts with a Middle East respiratory syndrome patient in a single Korean centre"},{"title3":"Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity"},{"title3":"Probable secondary infections in households of SARS patients in Hong Kong"},{"title3":"Risk factors for SARS infection among hospital healthcare workers in Beijing: a case control study"},{"title3":"Analysis of the spatio-temporal characteristics and transmission path of COVID-19 cluster cases in Zhuhai"},{"title3":"SARS among critical care nurses, Toronto"},{"title3":"A case-control study on the risk factors of severe acute respiratory syndromes among health care workers"},{"title3":"Rapid awareness and transmission of severe acute respiratory syndrome in Hanoi French Hospital, Vietnam"},{"title3":"Risk factors for SARS infection within hospitals in Hanoi, Vietnam"},{"title3":"Transmission of the severe acute respiratory syndrome on aircraft"},{"title3":"Lack of SARS transmission among healthcare workers, United States"},{"title3":"Factors associated with transmission of Middle East respiratory syndrome among Korean healthcare workers: infection control via extended healthcare contact management in a secondary outbreak hospital"},{"title3":"Lack of SARS transmission and U.S. SARS case-patient"},{"title3":"Investigation of the influencing factors on severe acute respiratory syndrome among health care workers"},{"title3":"Duration and distance of exposure are important predictors of transmission among community contacts of Ontario SARS cases"},{"title3":"Contact investigation for imported case of Middle East respiratory syndrome, Germany"},{"title3":"Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003"},{"title3":"Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea, in 2015"},{"title3":"Illness in intensive care staff after brief exposure to severe acute respiratory syndrome"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS)"},{"title3":"Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore"},{"title3":"SARS transmission in Vietnam outside of the health-care setting"},{"title3":"Epidemiological characteristics of COVID-19 in medical staff members of neurosurgery departments in Hubei province: a multicentre descriptive study"},{"title3":"Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand"},{"title3":"Asymptomatic SARS coronavirus infection among healthcare workers, Singapore"},{"title3":"Cluster of SARS among medical students exposed to single patient, Hong Kong"},{"title3":"Risk factors for SARS among persons without known contact with SARS patients, Beijing, China"},{"title3":"Effectiveness of personal protective measures in prevention of nosocomial transmission of severe acute respiratory syndrome"},{"title3":"Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients"},{"title3":"Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?"},{"title3":"Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff"},{"title3":"A randomized clinical trial of three options for N95 respirators and medical masks in health workers"},{"title3":"Chapter eight: it's not about the mask: SARS Commission final report, volume 3"},{"title3":"Ontario issues final SARS Commission report"},{"title3":"COVID-19: experts question guidance to reuse PPE"},{"title3":"Reuse of N95 masks"},{"title3":"Face masks for the public during the covid-19 crisis"},{"title3":"Airborne or droplet precautions for health workers treating coronavirus disease 2019?"},{"title3":"Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: a living systematic review of multiple streams of evidence"},{"title3":"Respiratory virus shedding in exhaled breath and efficacy of face masks"}]},{"title2":"Coronavirus Source Data","References":[]},{"title2":"World Bank Country and Lending Groups","References":[]},{"title2":"Confidence intervals for weighted proportions","References":[]},{"title2":"Transmission potential and severity of COVID-19 in South Korea","References":[{"title3":"Fitting dynamic models to epidemic outbreaks with quantified uncertainty: a primer for parameter uncertainty, identifiability, and forecasts"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"The effective reproduction number as a prelude to statistical estimation of time-dependent epidemic trends"},{"title3":"Early phylogenetic estimate of the effective reproduction number Of Sars-CoV-2"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission potential of the novel coronavirus (COVID-19) onboard the Diamond Princess Cruises Ship, 2020"},{"title3":"Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020"},{"title3":"Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014"},{"title3":"The ideal reporting interval for an epidemic to objectively interpret the epidemiological time course"},{"title3":"Serial interval of novel coronavirus (2019-nCoV) infections"},{"title3":"Estimation of the reproduction number for 2009 pandemic influenza A(H1N1) in the presence of imported cases"},{"title3":"Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Real-time forecasts of the COVID-19 epidemic in China from Feb 5 to Feb 24, 2020"},{"title3":"[An update on the epidemiological characteristics of novel coronavirus pneumoniaCOVID-19]"},{"title3":"Real-time monitoring the transmission potential of COVID-19 in Singapore, February 2020"},{"title3":"Assessing reporting delays and the effective reproduction number: the Ebola epidemic in DRC, May 2018-January 2019"},{"title3":"A generalized-growth model to characterize the early ascending phase of infectious disease outbreaks"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Estimation of the Time-Varying Reproduction Number of COVID-19 Outbreak in China"},{"title3":"Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis"},{"title3":"Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV"}]},{"title2":"Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":" Coronavirus disease 2019 (COVID-19) situation report:48. Published March 8, 2020. Accessed April 5, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4"},{"title3":"Defining the epidemiology of Covid-19:studies needed"},{"title3":"Serial interval of novel coronavirus (COVID-19) infections"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Viral load of SARS-CoV-2 in clinical samples"},{"title3":"Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020"},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak:United States, December 31, 2019-February 4, 2020"},{"title3":" Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Published February 28, 2020. Accessed April 5, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf"},{"title3":"First case of coronavirus disease 2019 (COVID-19) pneumonia in Taiwan"},{"title3":"Initial rapid and proactive response for the COVID-19 outbreak:Taiwan's experience"},{"title3":"Response to COVID-19 in Taiwan"},{"title3":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Taiwan Legislative Yuan. The Communicable Disease Control Act. Accessed April 18, 2020. https://law.moj.gov.tw/ENG/LawClass/LawAll.aspx?pcode=L0050001"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Real-time surveillance of infectious diseases: Taiwan's experience"},{"title3":" Clinical management of severe acute respiratory infection when COVID-19 is suspected. Published March 13, 2020. Accessed April 5, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":" Infectious disease contact tracing platform and management system. Accessed April 18, 2020. https://www.cdc.gov.tw/Professional/ProgramResultInfo/LeYn5b0UwF_lgvjR5rhT-A?programResultId=I2JMxghoGbL10LOSBG3h5Q"},{"title3":" The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. Published January 29, 2020. Accessed April 5, 2020. https://www.who.int/publications-detail/the-first-few-x-(ffx)-cases-and-contact-investigation-protocol-for-2019-novel-coronavirus-(2019-ncov)-infection"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Virological assessment of hospitalized patients with COVID-2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts"},{"title3":" Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. Published March 17, 2020. Assessed April 5, 2020. https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Potential association between COVID-19 mortality and health-care resource availability"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Backcalculating the incidence of infection with COVID-19 on the Diamond Princess"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"Extensive viable Middle East Respiratory Syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":" COVID-19 community mobility reports. Accessed April 16, 2020. https://www.google.com/covid19/mobility/"}]},{"title2":"Transmission dynamics, serial interval and epidemiology of COVID-19 diseases in Hong Kong under different control measures","References":[]},{"title2":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","References":[{"title3":"First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures and second-wave scenario planning: a modelling impact assessment"},{"title3":"To tame coronavirus, Mao-style social control blankets China"},{"title3":"Authoritarianism, outbreaks, and information politics"},{"title3":"Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19"},{"title3":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic"},{"title3":"Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong"},{"title3":"Responses to threat of influenza A(H7N9) and support for live poultry markets, Hong Kong, 2013"},{"title3":"EpiEstim: estimate time varying reproduction numbers from epidemic curves"},{"title3":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Improving the estimation of influenza-related mortality over a seasonal baseline"},{"title3":"Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong"},{"title3":"Ambient ozone and influenza transmissibility in Hong Kong"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Some problems in interval estimation"},{"title3":"Inferring influenza infection attack rate from seroprevalence data"},{"title3":"Mitigation of influenza B epidemic with school closures, Hong Kong, 2018"},{"title3":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve"},{"title3":"Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak"},{"title3":"Defining the epidemiology of COVID-19:studies needed"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Coronavirus: Why some countries wear face masks and others don't","References":[]},{"title2":"Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China","References":[]},{"title2":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study","References":[{"title3":"Using &quot;outbreak science&quot; to strengthen the use of models during epidemics"},{"title3":"Severe respiratory disease concurrent with the circulation of H1N1 influenza"},{"title3":"Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Characterizing Ebola transmission patterns based on internet news reports"},{"title3":"Pneumonia"},{"title3":"Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Hospitalizations for severe lower respiratory tract infections"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study"},{"title3":"Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine"},{"title3":"Exposure patterns driving ebola transmission in west Africa: A retrospective observational study"}]},{"title2":"Coming Together to Improve Data Collection in Uncertain Times","References":[]},{"title2":"Crowdsourcing data to mitigate epidemics","References":[{"title3":"Clock and TMRCA based on 27 genomes"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Do not violate the International Health Regulations during the COVID-19 outbreak"},{"title3":"The Economist"},{"title3":"Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Comparing national infectious disease surveillance systems: China and the Netherlands"}]}]},{"title1":"Social distancing to slow the US COVID-19 epidemic: Longitudinal pretestposttest comparison group study","References":[{"title2":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","References":[{"title3":"World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report - 66 (WHO, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=9e5b8b48_2."},{"title3":"&quot;'Not a wave, a tsunami.' Italy hospitals at virus limit,&quot; AP NEWS, 13 March 2020; https://apnews.com/a4497f31bf5dbc1ff263e4263fc9f69e."},{"title3":"&quot;COVID-19 infections rise in New York with peak weeks away.&quot; AP NEWS, 25 March 2020; https://apnews.com/7c7563cb82626a4042797c6aa6da260a."},{"title3":"SARS legacy: Outbreak reporting is expected and respected"},{"title3":"Centers for Disease Control and Prevention, Transcript for the CDC Telebriefing Update on COVID-19 (CDC, 2020); https://www.cdc.gov/media/releases/2020/t0225-cdc-telebriefing-covid-19.html."},{"title3":"The antigenic evolution of influenza: Drift or thrift?"},{"title3":"Complete genomic sequence of human coronavirus OC43: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Human coronavirus circulation in the United States 2014-2017"},{"title3":"Potential impact of seasonal forcing on a SARS-CoV-2 pandemic"},{"title3":"Absolute humidity and the seasonal onset of influenza in the continental United States"},{"title3":"Absolute humidity and pandemic versus epidemic influenza"},{"title3":"Conjunction of factors triggering waves of seasonal influenza"},{"title3":"The time course of the immune response to experimental coronavirus infection of man"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing"},{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"N. Thakkar, R. Burstein, H. Hu, P. Selvaraj, D. Klein, Institute for Disease Modeling, Bill &amp; Melinda Gates Foundation, Social distancing and mobility reductions have reduced COVID-19 transmission in King County, WA (Institute for Disease Modeling, 2020); https://covid.idmod.org/data/Social_distancing_mobility_reductions_reduced_COVID_Seattle.pdf."},{"title3":"N. M. Ferguson, D. Laydon, G. Nedjati-Gilani, N. Imai, K. Ainslie, M. Baguelin, S. Bhatia, A. Boonyasiri, Z. Cucunuba, G. Cuomo-Dannenburg, A. Dighe, H. Fu, K. Gaythorpe, H. Thompson, R. Verity, E. Volz, H. Wang, Y. Wang, P. G. Walker, C. Walters, P. Winskill, C. Whittaker, C. A. Donnelly, S. Riley, A. C. Ghani, Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand (Imperial College COVID-19 Response Team, 2020); https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf."},{"title3":"&quot;Coronavirus: Thousands of extra hospital beds and staff,&quot; BBC News, 21 March 2020; https://www.bbc.com/news/uk-51989183."},{"title3":"Makeshift hospitals for COVID-19 patients: Where health-care workers and patients need sufficient ventilation for more protection"},{"title3":"&quot;Pentagon says it will give 5 million respirators, 2,000 ventilators to Health and Human Services for virus response,&quot; AP NEWS, 17 March 2020; https://apnews.com/79e98812b5b1592a134803b00c8d88b0."},{"title3":"&quot;Coronavirus: How can China build a hospital so quickly?&quot; BBC News, 31 January 2020; https://www.bbc.com/news/world-asia-china-51245156."},{"title3":"Centers for Disease Control and Prevention, The National Respiratory and Enteric Virus Surveillance System (NREVSS) (CDC, 2020); https://www.cdc.gov/surveillance/nrevss/index.html."},{"title3":"Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: A statistical method"},{"title3":"Centers for Disease Control and Prevention, FluView Interactive (CDC, 2018); https://www.cdc.gov/flu/weekly/fluviewinteractive.htm."},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Driving factors of influenza transmission in the Netherlands"},{"title3":"The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application"},{"title3":"Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data"},{"title3":"World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report - 51 (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"What is the best control strategy for multiple infectious disease outbreaks?"},{"title3":"Public health interventions and epidemic intensity during the 1918 influenza pandemic"},{"title3":"The US 2009 A(H1N1) influenza epidemic: Quantifying the impact of school openings on the reproductive number"},{"title3":"James Cook University, State of the Tropics 2017 Report: Sustainable Infrastructure in the Tropics (James Cook University, 2017); https://www.jcu.edu.au/state-of-the-tropics/publications/2017."},{"title3":"Global spatio-temporal patterns of influenza in the post-pandemic era"},{"title3":"Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)"},{"title3":"Is COVID-19 receiving ADE from other coronaviruses?"},{"title3":"Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in China"},{"title3":"Influenza seasonality: Lifting the fog"},{"title3":"Ten weeks to crush the curve"},{"title3":"C. Tedijanto, c2-d2/CoV-seasonality: First release, Zenodo (2020); https://zenodo.org/record/3726085#.XpC68_7twwk."},{"title3":"S. Kissler, nCoV_introduction, Version 4.0, Zenodo (2020); https://zenodo.org/record/3745557#.XpC7Y_7twwk."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Comparison of three methods for selecting values of input variables in the analysis of output from a computer code"},{"title3":"Characterizing the reproduction number of epidemics with early subexponential growth dynamics"},{"title3":"R Core Team, R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2019); https://www.R-project.org/."},{"title3":"Solving differential equations in R: Package deSolve."}]},{"title2":"Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic","References":[]},{"title2":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities","References":[]},{"title2":"Strategies for containing an emerging influenza pandemic in Southeast Asia","References":[]},{"title2":"1918 influenza: the mother of all pandemics","References":[{"title3":"Statistics of influenza morbidity."},{"title3":"The geography and mortality of the 1918 influenza pandemic."},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic."},{"title3":"The incidence of neutralizing antibodies for swine influenza virus in the sera of human beings of different ages."},{"title3":"Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977-1978 to &quot;Scandinavian&quot; strains isolated in epidemics of 1950-1951."},{"title3":"Initial genetic characterization of the 1918 &quot;Spanish&quot; influenza virus."},{"title3":"Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes."},{"title3":"Origin and evolution of the 1918 &quot;Spanish&quot; influenza virus hemagglutinin gene."},{"title3":"Novel origin of the 1918 pandemic influenza virus nucleoprotein gene segment."},{"title3":"Characterization of the 1918 &quot;Spanish&quot; influenza virus matrix gene segment."},{"title3":"Characterization of the 1918 &quot;Spanish&quot; influenza virus neuraminidase gene."},{"title3":"1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants."},{"title3":"Characterization of the 1918 influenza virus polymerase genes."},{"title3":"The 1918 flu and other influenza pandemics: &quot;over there&quot; and back again."},{"title3":"Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus."},{"title3":"The 1918 influenza virus: a killer comes into view."},{"title3":"The recent epidemic of grip."},{"title3":"World War I may have allowed the emergence of &quot;Spanish&quot; influenza."},{"title3":"1917 avian influenza virus sequences suggest that the 1918 pandemic virus did not acquire its hemagglutinin directly from birds."},{"title3":"Relationship of pre-1918 avian influenza HA and NP sequences to subsequent avian influenza strains."},{"title3":"Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts."},{"title3":"Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid."},{"title3":"Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine)."},{"title3":"Avian influenza A viruses differ from human viruses by recognition of sialyloigosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site."},{"title3":"A single amino acid substitution in the 1918 influenza virus hemagglutinin changes the receptor binding specificity."},{"title3":"Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus."},{"title3":"Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus."},{"title3":"Pandemic versus epidemic influenza mortality: a pattern of changing age distribution."},{"title3":"The epidemiology of influenza."},{"title3":"Age and sex incidence of influenza and pneumonia morbidity and mortality in the epidemic of 1928-1929 with comparative data for the epidemic of 1918-1919."},{"title3":"Influenza: Learn from the past."},{"title3":"Re-emergence of fatal human influenza A subtype H5N1 disease."}]},{"title2":"Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: a modelling study","References":[{"title3":"Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study"}]},{"title2":"Andersen M. Early evidence on social distancing in response to COVID-19 in the United States. SSRN Working Paper No. 3569368 [preprint]. Amsterdam: Elsevier; 2020 [cited 2020 Jun 2]. Available from: https://ssrn.com/abstract=3569368.","References":[]},{"title2":"The immediate effect of COVID-19 policies on social distancing behavior in the United States","References":[{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"Defining the epidemiology of COVID-19:studies needed"},{"title3":"Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts"},{"title3":"Strategies for mitigating an influenza pandemic"},{"title3":"Social distance and SARS memory: impact on the public awareness of 2019 novel coronavirus (COVID-19) outbreak [online ahead of print, March 16, 2020]"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in China"},{"title3":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis"},{"title3":"When do shelter-in-place orders fight COVID-19 best? Policy heterogeneity across states and adoption time"},{"title3":"The effect of stay-at-home orders on COVID-19 infections in the United States [published online May 12, 2020]"},{"title3":"Staying at home: mobility effects of COVID-19. Center for Economic and Policy Research. May 12, 2020"},{"title3":"Strong social distancing measures in the United States reduced the COVID-19 growth rate"},{"title3":"Pandemic politics: timing state-level social distancing responses to COVID-19 [published online March 31, 2020]"},{"title3":"Political beliefs affect compliance with COVID-19 social distancing orders [published online March 6, 2020; revised July 7, 2020]"},{"title3":"Shelter-in-place orders reduced COVID-19 mortality and reduced the rate of growth in hospitalizations"},{"title3":"COVID-19 community mobility reports"},{"title3":"Google COVID-19 community mobility reports: anonymization process description (version 1.0) [published online April 8, 2020; revised April 9, 2020]"},{"title3":"State data and policy actions to address coronavirus"},{"title3":"Mandated and voluntary social distancing during the COVID-19 epidemic. Brookings Working Paper. Published June 25, 2020"},{"title3":"How much should we trust differences-in-differences estimates?"},{"title3":"Overwhelming number of smartphone users keep location services open. April 22, 2016"},{"title3":"The benefits and costs of using social distancing to flatten the curve for COVID-19"},{"title3":"Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. March 16, 2020"}]},{"title2":"Strong social distancing measures in the United States reduced the COVID-19 growth rate","References":[]},{"title2":"Dave DM, Friedson AI, Matsuzawa K, Sabia JJ. When do shelter-in-place orders fight COVID-19 best? Policy heterogeneity across states and adoption time. NBER Working Paper No. 27091 [preprint]. Cambridge: National Bureau of Economic Research; 2020 [cited 2020 Jun 2]. Available from: https://www.nber.org/papers/w27091.","References":[]},{"title2":"The effect of large-scale anti-contagion policies on the COVID-19 pandemic","References":[]},{"title2":"Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study","References":[{"title3":"Economic cost and health care workforce effects of school closures in the US"},{"title3":"Estimating the impact of school closure on influenza transmission from Sentinel data"},{"title3":"Measured voluntary avoidance behaviour during the 2009 A/H1N1 epidemic"},{"title3":"The effects of school closures on influenza outbreaks and pandemics: systematic review of simulation studies"},{"title3":"The epidemiology of hand, foot and mouth disease in Asia: a systematic review and analysis"},{"title3":"Economic activity and the spread of viral diseases: evidence from high frequency data"},{"title3":"The economy-wide impact of pandemic influenza and the UK: a computable general equilibrium modelling experiment"},{"title3":"The mathematics of infectious diseases"},{"title3":"Babysitting &amp; advanced child care certification"},{"title3":"Adaptive human behavior in epidemiological models"},{"title3":"Behavioural change models for infectious disease transmission: a systematic review (2010-2015)"},{"title3":"Interactive COVID-19 childcare map"},{"title3":"Evaluating targeted interventions via meta-population models with multi-level mixing"},{"title3":"School closures and influenza: systematic review of epidemiological studies"},{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"Open access epidemiological data from the COVID-19 outbreak"}]},{"title2":"Eichenbaum MS, Rebelo S, Trabandt M. The macroeconomics of epidemics. NBER Working Paper No. 26882 [preprint]. Cambridge: National Bureau of Economic Research; 2020 [cited 2020 Jun 2]. Available from: https://www.nber.org/papers/w26882.","References":[]},{"title2":"Petherick A, Hale T, Phillips T, Webster S. Variation in government responses to COVID-19. Blavatnik School Working Paper [preprint]. Oxford: University of Oxford Blavatnik School of Government; 2020 [cited 2020 Jun 2]. Available from: https://www.bsg.ox.ac.uk/research/publications/variation-government-responses-covid-19.","References":[]},{"title2":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","References":[]},{"title2":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020","References":[{"title3":"World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020. [Accessed 26 Jan 2020]. https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china "},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson NM. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/2019-nCoV-outbreak-report-22-01-2020.pdf "},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study."},{"title3":"The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020."},{"title3":"Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S, et al. Report 3: Transmissibility of 2019-nCoV. London; 2020. Available from: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-2019-nCoV-transmissibility.pdf "},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak."},{"title3":"Online repository. Boston: Laboratory for the Modeling of Biological and Socio-technical Systems (MOBS). [Accessed 29 Jan 2020]. Available from: https://docs.google.com/spreadsheets/d/1jS24DjSPVWa4iuxuD4OAXrE3QeI8c9BC1hSlqr-NMiU/edit#gid=1449891965 "},{"title3":"Stan Development Team. RStan: the R interface to Stan. R package version 2.18.2. 2018. Available from: https://cran.r-project.org/web/packages/rstan/vignettes/rstan.html "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"European Centre for Disease Prevention and Control (ECDC). Q &amp; A on novel coronavirus. Stockholm: ECDC; 2020. [Accessed 4 Feb 2020]. Available from: https://www.ecdc.europa.eu/en/novel-coronavirus-china/questions-answers "},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia."},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)."},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong."},{"title3":"Erratum to Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong."},{"title3":"Alternative methods of estimating an incubation distribution: examples from severe acute respiratory syndrome."},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan."},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility."},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Estimates of the severity of coronavirus disease 2019: a model-based analysis","References":[{"title3":"Coronavirus disease 2019 (COVID-19) situation report:43"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Report of the WHO-China Joint Mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Assessing the severity of the novel influenza A/H1N1 pandemic"},{"title3":"Potential biases in estimating absolute and relative case-fatality risks during outbreaks"},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: inference using exported cases"},{"title3":"Early epidemiological assessment of the transmission potential and virulence of 2019 novel coronavirus in Wuhan City: China, January-February, 2020"},{"title3":"2019-nCoV: preliminary estimates of the confirmed-case-fatality-ratio and infection-fatality-ratio, and initial pandemic risk assessment"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Ministry of Health, Labour and Welfare"},{"title3":"China statistical yearbook"},{"title3":"drjacoby"},{"title3":"CASEFAT: Stata module for estimating the case fatality ratio of a new infectious disease. Boston College of Economics"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Estimating the severity and subclinical burden of middle east respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia"},{"title3":"Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study"},{"title3":"Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1"},{"title3":"Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of 391 cases and 1,286 of their close contacts"}]},{"title2":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","References":[]},{"title2":"Social distancing to slow the U.S. COVID-19 epidemic: an interrupted time-series analysis","References":[]},{"title2":"Lancet Infectious Diseases Commission. Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission","References":[]},{"title2":"Mathematical models of infectious disease transmission","References":[]},{"title2":"Disease outbreak detection system using syndromic data in the greater Washington DC area","References":[]},{"title2":"Correcting for day of the week and public holiday effects: improving a national daily syndromic surveillance service for detecting public health threats","References":[{"title3":"Assessment of syndromic surveillance in Europe"},{"title3":"Syndromic surveillance - a public health legacy of the London 2012 Olympic and Paralympic Games"},{"title3":"Developing a new syndromic surveillance system for the London 2012 Olympic and Paralympic Games"},{"title3":"Establishing an emergency department syndromic surveillance system to support the London 2012 Olympic and Paralympic Games"},{"title3":"Harcourt SE, Morbey RA, Loveridge P, Carrilho L, Baynham D, Povey E, Fox P, Rutter J, Moores P, Tiffen J, et al. Developing and validating a new national remote health advice syndromic surveillance system in England. J Public health. 2016;39(1):184-92."},{"title3":"Visualization for modeling and simulation: visualization methods for time-dependent data - an overview"},{"title3":"Hauenstein L, Wojcik R, Loschen W, Ashar R, Sniegoski C, Tabernero N. Putting it together: the biosurveillance information system. In: Lombardo JS, Buckeridge DL, editors. Disease Surveillance A Public Health Informatics Approach. NJ: John Wiley &amp; Sons Inc; 2007."},{"title3":"Data visualisation for time series in environmental epidemiology"},{"title3":"Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK"},{"title3":"Morbey RA, Elliot AJ, Charlett A, Verlander NQ, Andrews N, Smith GE. The application of a novel 'rising activity, multi-level mixed effects, indicator emphasis' (RAMMIE) method for syndromic surveillance in England. Bioinformatics. 2015;31(22):3660-5."},{"title3":"Visualization techniques and graphical user interfaces in syndromic surveillance systems. Summary from the Disease Surveillance Workshop, Sept. 11-12, 2007; Bangkok, Thailand"},{"title3":"Research and Analysis: GP in hours bulletin. https://www.gov.uk/government/publications/gp-in-hours-bulletin. Accessed 12 May 2017."},{"title3":"Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience"},{"title3":"Syndromic surveillance: adapting innovations to developing settings"},{"title3":"Intra-Weekly Variations of Influenza-Like Illness in Military Populations"},{"title3":"Lessons from 40 years' surveillance of influenza in England and Wales"},{"title3":"Wong W-K, Moore AW. Classical Time-Series Methods for Biosurveillance. In: Wagner MM, Moore AW, Aryel RM, editors. Handbook of Biosurveillance. MA: Elsevier Academic Press; 2006."},{"title3":"Timeliness of syndromic influenza surveillance through work and school absenteeism"},{"title3":"Automated time series forecasting for biosurveillance"},{"title3":"A Spatiotemporal Analysis of Syndromic Data for Biosurveillance"},{"title3":"Statistical challenges in modern biosurveillance"},{"title3":"Wijk JJV, Selow ERV. Cluster and calendar based visualization of time series data. In: Information Visualization, 1999 (Info Vis '99) Proceedings 1999 IEEE Symposium; 1999. p. 4-9, 140."},{"title3":"Maciejewski R, Rudolph S, Grannis SJ, Ebert DS. The day-of-the-week effect: a study across the Indiana Public Health Emergency Surveillance System. International Society for Disease Surveillance Annual Conference Advances in Disease Surveillance 2008, 5(44)."},{"title3":"Engineering Statistics Handbook: e-Handbook of Statistical Methods. http://www.itl.nist.gov/div898/handbook/. Accessed 12 May 2017."},{"title3":"Statistical Challenges Facing Early Outbreak Detection in Biosurveillance"},{"title3":"Lotze T, Shmueli G, Murphy S, Burkom H. A wavelet-based anomaly detector for early detection of disease outbreaks. In: Workshop on Machine Learning Algorithms for Surveillance and Event Detection, 23rd Intl Conference on Machine Learning; 2006."},{"title3":"Siegrist D, McClellan G, Campbell M, Foster V, Burkom H, Hogan W, Cheng K, Buckeridge D, Pavlin J, Kress A. Evaluation of algorithms for outbreak detection using clinical data from five us cities. VA: Technical report, DARPA Bio-ALIRT Program; 2004."},{"title3":"Predicting Patient Visits to an Urgent Care Clinic Using Calendar Variables"},{"title3":"Predicting daily visits to a waik-in clinic and emergency department using calendar and weather data"},{"title3":"What are seasonal and meteorological factors are associated with the number of attendees at a sexual health service? An observational study between 2002-2012"},{"title3":"Internet-based remote health self-checker symptom data as an adjuvant to a national syndromic surveillance system"}]},{"title2":"Public health interventions and epidemic intensity during the 1918 influenza pandemic","References":[]},{"title2":"Job displacement and mortality: an analysis using administrative data","References":[]},{"title2":"Earnings losses of displaced workers","References":[]},{"title2":"Goodman-Bacon A. Difference-in-differences with variation in treatment timing. NBER Working Paper No. 25018 [preprint]. Cambridge: National Bureau of Economic Research; 2018 [cited 2020 Jun 2]. Available from: https://www.nber.org/papers/w25018.","References":[]},{"title2":"How much should we trust differences-in-differences estimates?","References":[]},{"title2":"The COVID-19 pandemic: government versus community action across the United States","References":[]},{"title2":"Estimation of excess deaths associated with the COVID-19 pandemic in the United States, March to May 2020","References":[]},{"title2":"Excess mortality in the United States during the peak of the COVID-19 pandemic","References":[]},{"title2":"Estimating the prevalence of COVID-19 in the United States: three complementary approaches","References":[]},{"title2":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","References":[{"title3":"First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures and second-wave scenario planning: a modelling impact assessment"},{"title3":"To tame coronavirus, Mao-style social control blankets China"},{"title3":"Authoritarianism, outbreaks, and information politics"},{"title3":"Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19"},{"title3":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic"},{"title3":"Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong"},{"title3":"Responses to threat of influenza A(H7N9) and support for live poultry markets, Hong Kong, 2013"},{"title3":"EpiEstim: estimate time varying reproduction numbers from epidemic curves"},{"title3":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Improving the estimation of influenza-related mortality over a seasonal baseline"},{"title3":"Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong"},{"title3":"Ambient ozone and influenza transmissibility in Hong Kong"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Some problems in interval estimation"},{"title3":"Inferring influenza infection attack rate from seroprevalence data"},{"title3":"Mitigation of influenza B epidemic with school closures, Hong Kong, 2018"},{"title3":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve"},{"title3":"Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak"},{"title3":"Defining the epidemiology of COVID-19:studies needed"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study","References":[]},{"title2":"Association between automotive assembly plant closures and opioid overdose mortality in the United States: a difference-in-differences analysis","References":[]},{"title2":"America's declining well-being, health, and life expectancy: not just a white problem","References":[]},{"title2":"U.S. county-level characteristics to inform equitable COVID-19 response","References":[{"title3":"Are Hospitals Near Me Ready for Coronavirus? Here Are Nine Different Scenarios"},{"title3":"Mapping the burden of COVID-"},{"title3":"Early Data Shows African Americans Have Contracted and Died of Coronavirus at an Alarming Rate"},{"title3":"Black Americans Face Alarming Rates of Coronavirus Infection in Some States"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) : United States, February 12-March 16, 2020"},{"title3":"This Chart Shows Why The Prison Population Is So Vulnerable to COVID-19"},{"title3":"Prisons And Jails Change Policies To Address Coronavirus Threat Behind Bars"},{"title3":"During the Covid-19 pandemic, nowhere is safe for homeless people"},{"title3":"Nursing Homes Are Ground Zero for COVID-19 Pandemic"},{"title3":"Health, Income, &amp; Poverty: Where We Are &amp; What Could Help"},{"title3":"Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1-7 million men and women"},{"title3":"Health Justice Strategies To Combat COVID-19: Protecting Vulnerable Communities During A Pandemic"},{"title3":"Location Data Says It All: Staying at Home During Coronavirus Is a Luxury"},{"title3":"New York City 2009 H1N1 Flu Investigation Team. Pandemic (H1N1)2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009"},{"title3":"Poorer NYC Neighborhoods Are Hit Hardest by Coronavirus"},{"title3":"A Month of Coronavirus in New York City: See the Hardest-Hit Areas"},{"title3":"Reassessing the Stroke Belt"},{"title3":"Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014"},{"title3":"Association Between Insurance Status and Access to Hospital Care in Emergency Department Disposition"},{"title3":"What Issues WII Uninsured People Face with Testing and Treatment for COVID-19?"},{"title3":"US jobless claims surge to record 3.3m as America locks down"},{"title3":"Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts"},{"title3":"Group Quarters Definitions - 2018 ACS 1-year and 2014-2018 ACS 5-year Data Releases: Technical Documentation - Survey ACS 2018 (5-Year Estimates)"},{"title3":"Why New York is the epicenter of the American coronavirus outbreak"},{"title3":"Eight Americas: Investigating Mortality Disparities across Races, Counties, and Race-Counties in the United States"},{"title3":"Vital Signs: Racial Disparities in Age-Specific Mortality Among Blacks or African Americans : United States, 1999-2015"},{"title3":"Opinion | The Racial Time Bomb in the Covid-19 Crisis"},{"title3":"Deaths: Final Data for 2017"},{"title3":"Biological Versus Chronological Aging"},{"title3":"Social Class Differentials in Health and Mortality: Patterns and Explanations in Comparative Perspective"},{"title3":"The Fall and Rise of US Inequities in Premature Mortality: 1960-2002"},{"title3":"Jim Crow and Premature Mortality Among the US Black and White Population, 1960-2009"},{"title3":"Where America Didn't Stay Home Even as the Virus Spread"},{"title3":"The Coronavirus Doesn't Discriminate, But U.S. Health Care Showing Familiar Biases"},{"title3":"Why Don't We Know Who the Coronavirus Victims Are?"},{"title3":"Elizabeth Warren and Ayanna Pressley are calling for racial data on coronavirus tests"},{"title3":"There are likely more unemployed Americans right now than at any time in history"},{"title3":"Addressing Social Determinants of Health: Time for a Polysocial Risk Score"},{"title3":"Coronavirus in the U.S.: Latest Map and Case Count"}]},{"title2":"Unequal protection: American inequality meets covid-19. The Economist. 2020 Apr 18.","References":[]},{"title2":"Authority to reopen U.S. for business in question","References":[]}]},{"title1":"Epidemiology of 2019 novel coronavirus in Jiangsu Province, China after wartime control measures: A population-level retrospective study","References":[{"title2":"A novel coronavirus outbreak of global health concern","References":[{"title3":"Novel coronavirus - Thailand (ex-China). Geneva: World Health Organization"},{"title3":"Novel Coronavirus - Japan (ex-China). Geneva: World Health Organization"},{"title3":"Update on the novel coronavirus pneumonia outbreak (Jan 24, 2020). Beijing: China National Health Commission"},{"title3":"Novel coronavirus - Republic of Korea (ex-China). Geneva: World Health Organization"},{"title3":"First travel-related case of 2019 novel coronavirus detected in United States. Atlanta, GA: US Centers for Disease Control and Prevention"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Novel coronavirus (2019-nCoV) situation report - 2 (22 January 2020). Geneva: World Health Organization"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV). Geneva: World Health Organization"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization"},{"title3":"Age- and sex-specific mortality associated with the 1918-1919 influenza pandemic in Kentucky"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, World Health Organization"},{"title3":"Announcement from the Headquarter for novel coronavirus pneumonia prevention and control (No 1). Beijing: China National Health Commission"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Geneva, World Health Organization"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","References":[{"title3":"Interspecies transmission and emergence of novel viruses: lessons from bats and birds"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Yuen KY; SARS study group. coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The neighbor-joining method: a new method for reconstructing phylogenetic trees"},{"title3":"Confidence limits on phylogenies: an approach using the bootstrap"},{"title3":"Evolutionary divergence and convergence in proteins"},{"title3":"MEGA x: Molecular evolutionary Genetics analysis across computing platforms"},{"title3":"The PSIPRED protein analysis Workbench: 20 years on"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (orf) 3b, orf 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein Is acquired from SARS-related coronavirus from Greater horseshoe bats through recombination"},{"title3":"SARS-Coronavirus Open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"The structure and functions of coronavirus genomic 3' and 5' ends"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"A new coronavirus associated with human respiratory disease in China","References":[]},{"title2":"The press conference on COVID-19 in Hubei","References":[]},{"title2":"Six weeks into the 2019 coronavirus disease (COVID-19) outbreak- it is time to consider strategies to impede the emergence of new zoonotic infections","References":[]},{"title2":"COVID-19: fighting panic with information","References":[]},{"title2":"A confirmed COVID-19 case in Suzhou was reported by the national health and Health Commission","References":[]},{"title2":"Presumed asymptomatic carrier transmission of COVID-19","References":[]},{"title2":"Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19","References":[{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"China restricts movement to fight coronavirus"},{"title3":"Fast detection is critical to contain deadly 2019 Wuhan coronavirus"},{"title3":"International travels and fever screening during epidemics: a literature review on the effectiveness and potential use of non-contact infrared thermometers"},{"title3":"Estimating the effective reproduction number of the 2019-nCoV in China"},{"title3":"China launches coronavirus &quot;close contact&quot; app"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak"},{"title3":"Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1)"},{"title3":"Using predicted imports of 2019-nCoV cases to determine locations that may not be identifying all imported cases"},{"title3":"Factors that make an infectious disease outbreak controllable"},{"title3":"Effectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infection"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus quarantine precautions around the world"},{"title3":"Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China"},{"title3":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screenedamong close contacts in Nanjing, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Report 3: transmissibility of 2019-nCoV"},{"title3":"South Korea and Vietnam are asking millions to stay home to avoid coronavirus as more people get infected and die outside of China"},{"title3":"A distinct name is needed for the new coronavirus"},{"title3":"Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study"},{"title3":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application"},{"title3":"Early transmission dynamics in Wuhan, China, of novel Coronavirus-Infected Pneumonia"},{"title3":"Time-varying transmission dynamics of novel coronavirus pneumonia in China"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"5 million left Wuhan before lockdown, 1,000 new coronavirus cases expected in city"},{"title3":"Airport screening for ebola: will it make a difference?"},{"title3":"A Chinese embassy in Paris tracked down a woman who gloated on social media about cheating airport detection with a medicine that lowered her fever"},{"title3":"A methodology for performing global uncertainty and sensitivity analysis in systems biology"},{"title3":"Estimating the asymptomatic ratio of 2019 novel coronavirus onboard the princess cruises ship, 2020"},{"title3":"Quantifying Bias of COVID-19 prevalence and severity estimates in Wuhan, China that depend on reported cases in international travelers"},{"title3":"The rate of underascertainment of novel coronavirus (2019-nCoV) Infection: estimation using Japanese passengers data on evacuation flights"},{"title3":"Thermal image scanning for influenza border screening: results of an airport screening study"},{"title3":"Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Pattern of early human-to-human transmission of wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020"},{"title3":"The novel coronavirus, 2019-nCoV, is highly contagious and more infectious than initially estimated"},{"title3":"Shadowy Church Is at Center of Coronavirus Outbreak in South Korea"},{"title3":"Some Schengen visa centers in China reopen, others remain closed indefinitely"},{"title3":"China's COVID-19 death toll tops 2,000; Iran reports first cases"},{"title3":"As cruise ship COVID-19 numbers climb, nations evacuate passengers"},{"title3":"China COVID-19 cases rise, as do worries over Diamond Princess risk"},{"title3":"Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions"},{"title3":"Comparison of infrared thermal detection systems for mass fever screening in a tropical healthcare setting"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)"},{"title3":"Coronavirus disease 2019 (COVID-19) Situation report 37"},{"title3":"Coronavirus disease 2019 (COVID-19) Situation report - 30"},{"title3":"Management of ill travellers at points of entry - international airports,seaports and ground crossings - in the context of COVID -19 outbreak"},{"title3":"Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"}]},{"title2":"Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread","References":[{"title3":"Emergence of a novel coronavirus causing respiratory illness from Wuhan, China"},{"title3":"Wuhan coronavirus outbreak.2 February 2020. https://www.worldometers.info/coronavirus/."},{"title3":"Government of Hong Kong SAR. Cross-boundary passenger traffic estimation and arrangements for Lunar New Year festive period. 7 Feb 2018. https://www.info.gov.hk/gia/general/201802/07/P2018020700291.htm."},{"title3":"The Japan Times. Japan reports first domestic transmission of coronavirus. 28 January 2020. https://www.japantimes.co.jp/news/2020/01/28/national/japan-first-domestic-transmission-coronavirus/."},{"title3":"Global News. German man who never visited china catches coronavirus through human-to-human transmission. 28 January 2020. https://globalnews.ca/news/6472303/german-coronavirus-human-to-human-transmission/."},{"title3":"CNN Health. First case of person-to-person transmission of Wuhan virus in the US confirmed. 30 January 2020. https://edition.cnn.com/2020/01/30/health/coronavirus-illinois-person-to-person-cdc/index.html."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Al Jazeera. Hong Kong cancels Chinese New Year celebrations. 18 January 2020. https://www.aljazeera.com/news/2020/01/hong-kong-cancels-chinese-year-celebrations-200118140832768.html."},{"title3":"The Washington Post. Chinese cities cancel New Year celebrations, travel ban widens in effort to stop coronavirus outbreak. 24 January 2020. https://www.washingtonpost.com/world/coronavirus-china-wuhan-latest/2020/01/23/2dc947a8-3d45-11ea-afe2-090eb37b60b1_story.html."},{"title3":"Temporal variation of human encounters and the number of locations in which they occur: a longitudinal study of Hong Kong residents"},{"title3":"South China Morning Post. Hong Kong schools, kindergartens closed until at least March 2 as coronavirus fears grow, three universities take similar action. 30 January 2020. https://www.scmp.com/news/hong-kong/education/article/3048305/hong-kong-universities-suspend-classes-until-march-china."},{"title3":"South China Morning Post. China coronavirus: hong kong will ban anyone who has been to Hubei province from entering city, in response to mounting calls to tighten border checks. 26 January 2020. https://www.scmp.com/news/hong-kong/health-environment/article/3047689/china-coronavirus-hong-kong-has-its-sixth-patient."}]},{"title2":"Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020","References":[{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."}]},{"title2":"COVID-19 control in China during mass population movements at New Year","References":[{"title3":"Updates on the epidemic"},{"title3":"Big data! The travel volume predictions during Lunar New Year holiday in 2020"},{"title3":"The press conference on COVID-19 in Hubei"},{"title3":"Location-based services of Baidu database"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"The State Council's announcement on the arrangement of public holidays in 2020"},{"title3":"The State Council's announcement on extending the Lunar New Year Holiday in 2020"},{"title3":"The press conference on Jan 26, 2020"},{"title3":"The announcement of cancellations of major events including temple fairs in Beijing"},{"title3":"The announcement from Wuhan's headquarter on the novel coronavirus prevention and control"},{"title3":"Spontaneous behavioural changes in response to epidemics"},{"title3":"Public health interventions and epidemic intensity during the 1918 influenza pandemic"},{"title3":"Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review"},{"title3":"Strategies for containing an emerging influenza pandemic in Southeast Asia"},{"title3":"Targeted social distancing designs for pandemic influenza"},{"title3":"Quantifying social distancing arising from pandemic influenza"},{"title3":"Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"The announcement from the Hubei Provincial Novel Coronavirus Pneumonia Prevention and Control Headquarter"},{"title3":"Companies can flexibly arrange jobs during the novel coronavirus epidemic except for those absolutely necessary for the normal operation of cities"},{"title3":"The announcement on postponing the reoperation date of companies and the reopening date of schools"},{"title3":"The announcement on postponing the reoperation date of companies and the reopening date of schools"},{"title3":"Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings:social distancing measures"}]},{"title2":"Facing the COVID-19 outbreak: what should we know and what could we do?","References":[{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"  . Coronavirus disease 2019 (COVID-2019) situation report:37. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200226-sitrep-37-covid-19.pdf?sfvrsn=6126c0a4_2 "},{"title3":"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"What to do next to control the 2019-nCoV epidemic?"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"First case of 2019 novel coronavirus in the United States"}]},{"title2":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC)"},{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS coronavirus outbreak: implications for emerging viral infections"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Helicobacter pylori multiplex serology"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"SARS: epidemiology"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012-2015"},{"title3":"Estimating the risk of Middle East Respiratory Syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Severe Acute Respiratory Syndrome (SARS)-lessons for future pandemics"},{"title3":"Public Health Network Structure and Collaboration Effectiveness during the 2015 MERS outbreak in South Korea: an institutional collective action framework"},{"title3":"Leung Gm Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"CDC. CDC Advises Travelers to Avoid All Nonessential Travel to China. https://www.cdc.gov/media/releases/2020/s0128-travelers-avoid-china.html (2 April 2020, date last accessed)."}]},{"title2":"Passengers' destinations from China: low risk of novel coronavirus (2019-nCoV) transmission into Africa and South America","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":". Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Tracing the largest seasonal migration on earth"},{"title3":"What kinds of Chinese 'geese' are flying to Africa? Evidence from Chinese manufacturing firms"},{"title3":"The evolution of China's international aviation markets from a policy perspective on air passenger flows"},{"title3":"FLIRT-ing with Zika: a web application to predict the movement of infected travelers validated against the current zika virus epidemic"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"SARS to novel coronavirus - old lessons and new lessons"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges","References":[]},{"title2":"The number of confirmed COVID-19 case was reported by the national health and Health Commission","References":[]}]},{"title1":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","References":[{"title2":"First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures and second-wave scenario planning: a modelling impact assessment","References":[{"title3":"Hubei district launches wartime control order to better fight virus"},{"title3":"Daily briefing on the prevention and control of the transmission of the novel coronavirus in Beijing"},{"title3":"Press release on the prevention and control of the novel coronavirus in Shanghai"},{"title3":"Confirmed cases of the novel coronavirus pneumonia in Shenzhen"},{"title3":"Outbreak of novel coronavirus pneumonia in Wenzhou (daily updates)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China"},{"title3":"Line list of 2019-nCoV confirmed fatal cases (from publicly available information)"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks"},{"title3":"Under-reporting and estimates for emerging epidemics"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Early dynamics of transmission and control of COVID-19: a mathematical modelling study"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Coronavirus COVID-19 global cases by the Centre for Systems Science Engineering (CSSE) at Johns Hopkins"},{"title3":"Epidemiological characteristics of influenza in Guangdong province, during winter of 2017-2018"},{"title3":"Social distance and SARS memory: impact on the public awareness of 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Research report of the application of data and intelligence in the prevention and control of the COVID-19 epidemic"},{"title3":"In coronavirus fight, China gives citizens a color code, with red flags"},{"title3":"National data"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China"},{"title3":"What can we learn from China's health system reform?"},{"title3":"The primary health-care system in China"},{"title3":"Hospitals in China, overwhelmed by coronavirus, turn away patients with other pressing needs"},{"title3":"Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Unraveling the drivers of MERS-CoV transmission"}]},{"title2":"To tame coronavirus, Mao-style social control blankets China","References":[]},{"title2":"Authoritarianism, outbreaks, and information politics","References":[{"title3":"Democracy and health"},{"title3":"Democracy and human development"},{"title3":"The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis"},{"title3":"Wuhan, center of coronavirus outbreak, is being cut off by Chinese authorities"},{"title3":"WHO Emergencies Coronavirus Emergency Committee Second Meeting"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"China silences critics over deadly virus outbreak"},{"title3":"The mystery of the Wuhan epidemic: evidence from reptiles and text analysis"},{"title3":"Wuhan Mayor offers to resign over coronavirus response"},{"title3":"Questions and answers on pneumonia epidemic and new coronavirus infection. [In Chinese.]"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"}]},{"title2":"Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19","References":[{"title3":"Centre for Health Protection (CHP). Flu Express. Volume 15, Number 52. Hong Kong: CHP; 2019. Available from: https://www.chp.gov.hk/files/pdf/fluexpress_week52_3_1_2019_eng.pdf."},{"title3":"Centre for Health Protection (CHP). Flu Express. Volume 16, Number 01. Hong Kong: CHP; 2019. Available from: https://www.chp.gov.hk/files/pdf/flux_wk1_10_1_2019_eng.pdf "},{"title3":"The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013."},{"title3":"Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study."},{"title3":"Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/2017."},{"title3":"The test-negative design for estimating influenza vaccine effectiveness."},{"title3":"Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review."},{"title3":"Centers for Disease Control and Prevention (CDC). CDC's Advisory Committee on Immunization Practices (ACIP) Recommends Universal Annual Influenza Vaccination. Atlanta: CDC; 2010. Available from: https://www.cdc.gov/media/pressrel/2010/r100224.htm "},{"title3":"Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness."},{"title3":"Centre for Health Protection (HCP). Statistics on 2018/19 Vaccination Programmes / Schemes. Hong Kong: CHP; Last accessed on Jan 18 2019. Available from: https://www.chp.gov.hk/en/features/26734.html."},{"title3":"Is It Possible to Get a Flu Shot Too Early?"},{"title3":"Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019."},{"title3":"Sparse data bias: a problem hiding in plain sight."}]},{"title2":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic","References":[]},{"title2":"Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong","References":[]},{"title2":"Responses to threat of influenza A(H7N9) and support for live poultry markets, Hong Kong, 2013","References":[{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases."},{"title3":"Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study."},{"title3":"Global concerns regarding novel influenza A (H7N9) virus infections."},{"title3":"Longitudinal assessment of community psychobehavioral responses during and after the 2003 outbreak of severe acute respiratory syndrome in Hong Kong."},{"title3":"Community psychological and behavioral responses through the first wave of the 2009 influenza A (H1N1) pandemic in Hong Kong."},{"title3":"Changing perception of avian influenza risk, Hong Kong, 2006-2010."},{"title3":"A procedure for objective respondent selection within the household."},{"title3":"Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013."},{"title3":"Live poultry exposure, Guangzhou, China, 2006."},{"title3":"Avian influenza risk perception and live poultry purchase in Guangzhou, China, 2006."},{"title3":"Avian influenza and ban on overnight poultry storage in live poultry markets, Hong Kong."}]},{"title2":"EpiEstim: estimate time varying reproduction numbers from epidemic curves","References":[]},{"title2":"Improved inference of time-varying reproduction numbers during infectious disease outbreaks","References":[{"title3":"Middle East respiratory syndrome coronavirus in healthcare settings"},{"title3":"Transmission dynamics of the 2009 influenza A (H1N1) pandemic in India: the impact of holiday-related school closure"},{"title3":"Global hotspots and correlates of emerging zoonotic diseases"},{"title3":"Rapid drop in the reproduction number during the Ebola outbreak in the Democratic Republic of the Congo"},{"title3":"Estimation of time-dependent reproduction numbers for porcine reproductive and respiratory syndrome across different regions and production systems of the US"},{"title3":"Spatiotemporal analysis of the 2014 Ebola epidemic in West Africa"},{"title3":"Temporal changes in Ebola Transmission in Sierra Leone and implications for control requirements: a real-time modelling study"},{"title3":"Bayesian inference of transmission chains using timing of symptoms, pathogen genomes and contact data"},{"title3":"Estimating in real time the efficacy of measures to control emerging communicable diseases"},{"title3":"Real-time estimates in early detection of SARS"},{"title3":"Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States"},{"title3":"Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"New technologies in predicting, preventing and controlling emerging infectious diseases"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"Key data for outbreak evaluation: building on the Ebola experience"},{"title3":"A graph-based evidence synthesis approach to detecting outbreak clusters: an application to dog rabies"},{"title3":"Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households"},{"title3":"Estimation of the serial interval of influenza"},{"title3":"The effective reproduction number of pandemic influenza: prospective estimation"},{"title3":"Optimising and communicating options for the control of invasive plant disease when there is epidemiological uncertainty"},{"title3":"Modeling when, where, and how to manage a forest epidemic, motivated by sudden oak death in California"},{"title3":"Unreported cases in the 2014-2016 Ebola epidemic: spatiotemporal variation, and implications for estimating transmission"},{"title3":"Emerging infectious diseases of wildlife - threats to biodiversity and human health"},{"title3":"Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations"},{"title3":"Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995"},{"title3":"A simple model for complex dynamical transitions in epidemics"},{"title3":"Scientific opinion on the risk to plant health posed by Xylella fastidiosa in the EU territory, with the identification and evaluation of risk reduction options"},{"title3":"The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions"},{"title3":"Countering the Zika epidemic in Latin America"},{"title3":"The interval between successive cases of an infectious disease"},{"title3":"Emerging fungal threats to animal, plant and ecosystem health"},{"title3":"Seasonality of infectious diseases"},{"title3":"A likelihood-based method for real-time estimation of the serial interval and reproductive number of an epidemic"},{"title3":"Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA"},{"title3":"Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda"},{"title3":"Estimating individual and household reproduction numbers in an emerging epidemic"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Mers-CoV at the animal-human interface: inputs on exposure pathways from an expert-opinion elicitation"},{"title3":"Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data"},{"title3":"Estimating reproduction numbers for adults and children from case data"},{"title3":"Seasonal infectious disease epidemiology"},{"title3":"Joint estimation of the basic reproduction number and generation time parameters for infectious disease outbreaks"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Accurate forecasts of the effectiveness of interventions against Ebola may require models that account for variations in symptoms during infection"},{"title3":"Exposure patterns driving Ebola transmission in West Africa"},{"title3":"Bayesian reconstruction of disease outbreaks by combining epidemiological and genomic data"},{"title3":"Global trends in emerging infectious diseases"},{"title3":"Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape"},{"title3":"Models of foot-and-mouth disease"},{"title3":"Projections of Ebola outbreak size and duration with and without vaccine use in Equateur, Democratic Republic of the Congo, as of May 27, 2019"},{"title3":"Impact of interventions and the incidence of ebola virus disease in Liberia - implications for future epidemics"},{"title3":"Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school"},{"title3":"Invited commentary: real-time tracking of control measures for emerging infections"},{"title3":"Opinion: mathematical models: a key tool for outbreak response"},{"title3":"Seasonal population dynamics and behaviour of insects in models of vector-borne pathogens"},{"title3":"A statistical framework for the adaptive management of epidemiological interventions"},{"title3":"Opportunities and challenges in modeling emerging infectious diseases"},{"title3":"The challenge of emerging and re-emerging infectious diseases"},{"title3":"Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009"},{"title3":"How decision makers can use quantitative approaches to guide outbreak responses"},{"title3":"A simple approach to measure transmissibility and forecast incidence"},{"title3":"The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks"},{"title3":"MVSE: an R-package that estimates a climate-driven mosquito-borne viral suitability index"},{"title3":"Transmissibility of 2009 pandemic influenza A (H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations"},{"title3":"A practical generation-interval-based approach to inferring the strength of epidemics from their speed"},{"title3":"Outbreak analytics: a developing data science for informing the response to emerging pathogens"},{"title3":"Estimating incubation periods with coarse data"},{"title3":"Adaptive management and the value of information: learning via intervention in epidemiology"},{"title3":"Economic and disease burden of dengue in Southeast Asia"},{"title3":"Risk factors for human disease emergence"},{"title3":"Modeling the spread and control of foot-and-mouth disease in Pennsylvania following its discovery and options for control"},{"title3":"Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study"},{"title3":"Detecting presymptomatic infection is necessary to forecast major epidemics in the earliest stages of infectious disease outbreaks"},{"title3":"Control fast or control smart? When should invading pathogens be controlled?"},{"title3":"Detection, forecasting and control of infectious disease epidemics: modelling outbreaks in humans, animals and plants"},{"title3":"Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic"},{"title3":"Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases"},{"title3":"Nowcasting the number of new symptomatic cases during infectious disease outbreaks using constrained P-spline smoothing"},{"title3":"Determinants of rotavirus transmission. A lag nonlinear time series analysis"},{"title3":"Serial intervals of respiratory infectious diseases: a systematic review and analysis"},{"title3":"Different epidemic curves for Severe Acute Respiratory Syndrome reveal similar impacts of control measures"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Optimizing infectious disease interventions during an emerging epidemic"},{"title3":"Ebola virus disease in West Africa : the first 9 months of the epidemic and forward projections"},{"title3":"Responding to the threat of urban yellow fever outbreaks"},{"title3":"A one-year effective reproduction number of the 2014-2015 Ebola outbreaks in the widespread West African countries and quantitative evaluation of air travel restriction measure"},{"title3":"Finding evidence for local transmission of contagious disease in molecular epidemiological datasets"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Improving the estimation of influenza-related mortality over a seasonal baseline","References":[{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"Predicting the epidemic sizes of influenza A/H1N1, A/H3N2 and B: a statistical method"},{"title3":"Estimates of US influenza-associated deaths made using four different methods"},{"title3":"Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data"},{"title3":"Methods for current statistical analysis of excess pneumonia-influenza deaths"},{"title3":"The impact of influenza epidemics on mortality: introducing a severity index"},{"title3":"Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong"},{"title3":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine"},{"title3":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine"},{"title3":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003"},{"title3":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States"},{"title3":"Holiday spikes in pneumococcal disease among older adults"},{"title3":"Estimating influenza-associated deaths in the United States"},{"title3":"Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010"},{"title3":"Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates"},{"title3":"Mortality and influenza"},{"title3":"The Size and Power of the Bias-Corrected Bootstrap Test for Regression Models with Autocorrelated Errors"},{"title3":"Winter mortality modifies the heat-mortality association the following summer"},{"title3":"Summer temperature-related mortality: effect modification by previous winter mortality"},{"title3":"Estimating deaths due to influenza and respiratory syncytial virus"},{"title3":"Influenza and the winter increase in mortality in the United States, 1959-1999"},{"title3":"Estimates of deaths associated with seasonal influenza --- United States, 1976-2007"},{"title3":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)"},{"title3":"A Maximum Likelihood Procedure for Regression with Autocorrelated Errors"}]},{"title2":"Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong","References":[]},{"title2":"Ambient ozone and influenza transmissibility in Hong Kong","References":[{"title3":"Environmental role in influenza virus outbreaks"},{"title3":"Modulation of host defenses by exposure to oxidant air pollutants"},{"title3":"Driving factors of influenza transmission in the netherlands"},{"title3":"Improving the estimation of influenza-related mortality over a seasonal baseline"},{"title3":"Brief Original Contribution Infection Fatality Risk of the Pandemic A (H1N1) 2009 Virus in Hong Kong"},{"title3":"A new framework and software to estimate time-varying reproduction numbers during epidemics"},{"title3":"The serial intervals of seasonal and pandemic influenza viruses in households in Bangkok, Thailand"},{"title3":"Dynamical resonance can account for seasonality of influenza epidemics"},{"title3":"Ozone for inactivation of aerosolized bacteriophages"},{"title3":"Integrated science assessment for ozone and related photochemical oxidants"},{"title3":"IL-33 Drives Augmented Responses to Ozone in Obese Mice"},{"title3":"The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses"},{"title3":"Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection"},{"title3":"IL-33 isoforms: their future as vaccine adjuvants?"}]},{"title2":"A new framework and software to estimate time-varying reproduction numbers during epidemics","References":[{"title3":"Strategies for mitigating an influenza pandemic"},{"title3":"Factors that make an infectious disease outbreak controllable"},{"title3":"Directly transmitted infectious diseases: control by vaccination"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain"},{"title3":"Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark, Norway and Sweden"},{"title3":"Real time Bayesian estimation of the epidemic potential of emerging infectious diseases"},{"title3":"The estimation of the effective reproductive number from disease outbreak data"},{"title3":"Estimation of a time-varying force of infection and basic reproduction number with application to an outbreak of classical swine fever"},{"title3":"Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"Real-time estimates in early detection of SARS"},{"title3":"Estimating in real time the efficacy of measures to control emerging communicable diseases"},{"title3":"Temporal variability and social heterogeneity in disease transmission: the case of SARS in Hong Kong"},{"title3":"Transmissibility of the influenza virus in the 1918 pandemic"},{"title3":"Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009"},{"title3":"Estimating individual and household reproduction numbers in an emerging epidemic"},{"title3":"Influenza transmission in households during the 1918 pandemic"},{"title3":"Viral shedding and clinical illness in naturally acquired influenza virus infections"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps)"},{"title3":"Transmission potential of smallpox: estimates based on detailed data from an outbreak"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza"},{"title3":"Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis"},{"title3":"New strategies for the elimination of polio from India"},{"title3":"The effective reproduction number of pandemic influenza: prospective estimation"},{"title3":"Estimation of the reproduction number for 2009 pandemic influenza A(H1N1) in the presence of imported cases&quot; [letter]"},{"title3":"Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations"},{"title3":"Bayesian inference for contact networks given epidemic data"},{"title3":"Influenza in Maryland: preliminary statistics of certain localities"},{"title3":"Estimates of the reproduction numbers of Spanish influenza using morbidity data"},{"title3":"Strategies for containing an emerging influenza pandemic in Southeast Asia"},{"title3":"Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review"},{"title3":"Transmission potential of smallpox in contemporary populations"},{"title3":"Smallpox transmission and control: spatial dynamics in Great Britain"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"}]},{"title2":"How generation intervals shape the relationship between growth rates and reproductive numbers","References":[]},{"title2":"Some problems in interval estimation","References":[]},{"title2":"Inferring influenza infection attack rate from seroprevalence data","References":[{"title3":"Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling"},{"title3":"Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1"},{"title3":"Fineberg HV, Aavitsland P, Aditama T, Bino S, Carmo EH, .. (2011) Implementation of the international health regulations (2005): report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza A(H1N1) 2009. Geneva: World Health Organization."},{"title3":"Seroprevalence to influenza A(H1N1) 2009 virus-where are we?"},{"title3":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries"},{"title3":"Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic"},{"title3":"Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study"},{"title3":"Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period"},{"title3":"Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December, 2009"},{"title3":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study"},{"title3":"The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong"},{"title3":"Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation"},{"title3":"Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data"},{"title3":"Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida-November-December, 2009"},{"title3":"Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic"},{"title3":"Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, .. (2012) Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: Springer. 298 p."},{"title3":"Age-Dependent Patterns of Infection and Severity Explaining the Low Impact of 2009 Influenza A (H1N1): Evidence From Serial Serologic Surveys in the Netherlands"},{"title3":"Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture models"},{"title3":"The burden of parvovirus B19 infection in women of childbearing age in England and Wales"},{"title3":"The Effective Reproduction Number of Pandemic Influenza: Prospective Estimation"},{"title3":"School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong"},{"title3":"The infection attack rate and severity of 2009 pandemic influenza (H1N1) in Hong Kong"},{"title3":"Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009"},{"title3":"Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations"},{"title3":"Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households"},{"title3":"Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases"},{"title3":"Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review"},{"title3":"Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States"},{"title3":"Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza"},{"title3":"Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1"},{"title3":"Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus"},{"title3":"Comparison of influenza serological techniques by international collaborative study"},{"title3":"Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong"},{"title3":"Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus"},{"title3":"Seasonality of influenza A(H3N2) virus: a Hong Kong perspective (1997-2006)"},{"title3":"Influenza infection rates, measurement errors and the interpretation of paired serology"},{"title3":"Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London"},{"title3":"Estimate of 2009 H1N1 influenza cases in Shenzhen-the biggest migratory city in China"}]},{"title2":"Mitigation of influenza B epidemic with school closures, Hong Kong, 2018","References":[{"title3":"A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998-2013."},{"title3":"Effects of school closures, 2008 winter influenza season, Hong Kong."},{"title3":"School closure and mitigation of pandemic (H1N1) 2009, Hong Kong."},{"title3":"Local situation of influenza activity (as of Feb 7, 2018)"},{"title3":"Update: influenza activity:United States, October 1, 2017-February 3, 2018."},{"title3":"Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong."},{"title3":"Ambient ozone and influenza transmissibility in Hong Kong."},{"title3":"Influenza virus subtyping in 2018"},{"title3":"Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method."},{"title3":"Estimating in real time the efficacy of measures to control emerging communicable diseases."},{"title3":"Comparative epidemiology of pandemic and seasonal influenza A in households."},{"title3":"Closure of schools during an influenza pandemic."},{"title3":"Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18."}]},{"title2":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve","References":[]},{"title2":"Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020."},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020."},{"title3":"Cohen E. China says coronavirus can spread before symptoms show -- calling into question US containment strategy. Atlanta: CNN. [Accessed 4 Feb 2020]. Available from: https://edition.cnn.com/2020/01/26/health/coronavirus-spread-symptoms-chinese-officials/index.html "},{"title3":"Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections."},{"title3":"Recognition of aerosol transmission of infectious agents: a commentary."},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome."},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus."},{"title3":"Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy."},{"title3":"Swift R. Sixty more people confirmed with coronavirus on cruise ship in Japan: media. Tokyo: Reuters. [Accessed 10 Feb 2020]. Available from: https://www.reuters.com/article/us-china-health-japan/sixty-more-people-confirmed-with-coronavirus-on-cruise-ship-in-japan-media-idUSKBN2040FG "},{"title3":"MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015."},{"title3":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro."},{"title3":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins."},{"title3":"Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures."},{"title3":"Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing Measures."},{"title3":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities."},{"title3":"Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 European Union/European Economic Area countries, January 2020."}]},{"title2":"Defining the epidemiology of COVID-19:studies needed","References":[]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: World Health Organization, 2004 ()."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study."},{"title3":"Influenza A virus shedding and infectivity in households."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany."}]}]}]}